Login / Signup

Deconstructing the 2023 Clinical Laboratory and Standards Institute Revised Piperacillin-tazobactam Breakpoints Against Pseudomonas aeruginosa.

Pranita D TammaPatrick N A HarrisAmy J MathersEric WenzlerRomney M Humphries
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Keyphrases
  • pseudomonas aeruginosa
  • cystic fibrosis
  • biofilm formation
  • acinetobacter baumannii
  • gram negative
  • drug resistant